Common Contracts
2 similar Securities Purchase Agreement contracts by Idera Pharmaceuticals, Inc.
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • July 15th, 2020 • Idera Pharmaceuticals, Inc. • Biological products, (no disgnostic substances) • New York
This Securities Purchase Agreement (this “Agreement”) is made and entered into as of July 13, 2020 (the “Effective Date”) by and among Idera Pharmaceuticals, Inc., a Delaware corporation (the “Company”), and entities controlled by Pillar Invest Corporation, Cayman Islands limited partnerships, set forth on Schedule A hereto (each a “Purchaser” and together the “Purchasers”). Certain terms used and not otherwise defined in the text of this Agreement are defined in Section 11 hereof.
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • April 7th, 2020 • Idera Pharmaceuticals, Inc. • Biological products, (no disgnostic substances) • New York
This Securities Purchase Agreement (this “Agreement”) is made and entered into as of April 7, 2020 (the “Effective Date”) by and among Idera Pharmaceuticals, Inc., a Delaware corporation (the “Company”), and Pillar Partners Foundation, L.P., a Cayman Islands limited partnership (the “Purchaser”). Certain terms used and not otherwise defined in the text of this Agreement are defined in Section 11 hereof.
